Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jingting Min
Observed names:
J T Min,
Jing-Ting Min,
Min Jingting,
Min, Jingting
Institution:
Bengbu Medical College
Observed institution:
Bengbu Medical College
ORCID:
0000-0002-6739-2892
Observed ORCID:
0000-0002-6739-2892
OpenAlex ID:
A5010105557
c-Met specific CAR-T cells as a targeted therapy for non-small cell lung cancer cell A549
2022
·
Jingting Min
, Chirong Long
, et al.
·
Bioengineered
·
30
The prognostic role of lymphocyte-to-monocyte ratio in patients with resectable pancreatic cancer: a systematic review and meta-analysis
2024
·
Haipeng Li
, Shang Peng
, et al.
·
PeerJ
·
9
[Bioinformatic prediction and validation of cellular-mesenchymal epithelial transition(c-Met) as a target for chimeric antigen receptor T (CAR-T) cell therapy in the treatment of colorectal cancer].
2024
·
Shang Peng
, Jingting Min
, et al.
·
PubMed
·
2
Tecartus Real-World Adverse Event Reporting System in a Middle-Aged and Elderly Population: A FAERS-Based Pharmacovigilance Study
2026
·
Haipeng Li
, Jiaqi Yan
, et al.
·
Technology in Cancer Research & Treatment
·
1
Study on the in vitro and in vivo killing effects of PD-1 antibody-secreting c-Met-targeted CAR-T cells on esophageal cancer cell line ECA109
2025
·
Shang Peng
, Yanqiu Li
, et al.
·
Discover Oncology
·
1
PDF
[Study on construction of c-Met specific CAR-T cells and its killing effect on non-small cell lung carcinoma].
2023
·
J T Min
, L Zhang
, et al.
·
PubMed
·
1
Author response for "Tecartus real-world adverse event reporting system in a middle-aged and elderly population: a FAERS-based pharmacovigilance study"
2026
·
Haipeng Li
, Jiaqi Yan
, et al.
·
Publons reviews and discussion
Author response for "Tecartus real-world adverse event reporting system in a middle-aged and elderly population: a FAERS-based pharmacovigilance study"
2026
·
Haipeng Li
, Jiaqi Yan
, et al.
·
Publons reviews and discussion
Mechanistic insights into c-Met rs368750834 mutation and a bifunctional CAR-T strategy for serous ovarian carcinoma
2025
·
Yanqiu Li
, Haipeng Li
, et al.
·
Journal of Ovarian Research
PDF
[Research progress in the developmental process of non-viral CAR-T technology].
2025
·
Haipeng Li
, Qiyu Zhu
, et al.
·
PubMed
[c-Met-targeted chimeric antigen receptor T cells inhibit human serous ovarian cancer cell SKOV-3 in vitro].
2025
·
Na-Na DU
, Yan-Jun Zhang
, et al.
·
PubMed
[Intraperitoneal injection of human-derived anti-c-Met single-chain antibody inhibits the growth of transplanted tumours in A549 lung adenocarcinoma-loaded mice].
2024
·
Ran An
, Mingzhu Liu
, et al.
·
PubMed
A novel cuproptosis-related LncRNA signature predicts prognosis inpatients with esophageal carcinoma
2023
·
Shang peng
, Li Haipeng
, et al.
·
Research Square
PDF
c-Met specific CAR-T cells as a targeted therapy for non-small cell lung cancer cell A549
2022
·
Min, Jingting
, Long, Chirong
, et al.
·
Figshare
Advances and challenges in the treatment of solid tumors with chimeric antigen receptor T cells
2020
·
Min Jingting
, Zhenghong Li
[Establishment of a dual-fluorescence-traced lung cancer subcutaneous transplantation model in nude mice].
2019
·
H L Fan
, M Z Liu
, et al.
·
PubMed
Show more works
View as search
Works count:
16
Citation count:
44
H-index:
2
I10-index:
1
Year
Topic
Type